{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:32:57Z","timestamp":1794537177710,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is an urgent need to develop phage therapies for multidrug-resistant bacterial infections. However, although bacteria have been shown to be susceptible to phage therapy, phage therapy is not sufficient in some cases. PhiMR003 is a methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> phage previously isolated from sewage influent, and it has demonstrated high lytic activity and a broad host range to MRSA clinical isolates in vitro. To investigate the potential of phiMR003 for the treatment of MRSA infection, the effects of phiMR003 on immune responses in vivo were analysed using phiMR003-susceptible MRSA strains in a mouse wound infection model. Additionally, we assessed whether phiMR003 could affect the immune response to infection with a nonsusceptible MRSA strain. Interestingly, wounds infected with both susceptible and nonsusceptible MRSA strains treated with phiMR003 demonstrated decreased bacterial load, reduced inflammation and accelerated wound closure. Moreover, the infiltration of inflammatory cells in infected tissue was altered by phiMR003. While the effects of phiMR003 on inflammation and bacterial load disappeared with heat inactivation of phiMR003. Transcripts of proinflammatory cytokines induced by lipopolysaccharide were reduced in mouse peritoneal macrophages. These results show that the immune modulation occurring as a response to the phage itself improves the clinical outcomes of phage therapy.<\/jats:p>","DOI":"10.1038\/s41598-022-19922-x","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T10:03:32Z","timestamp":1663581812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection"],"prefix":"10.1038","volume":"12","author":[{"given":"Tomoya","family":"Suda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Tanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Miyanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Hasegawa-Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Kizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"19922_CR1","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3201\/eid2704.204036","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel, A. et al. Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units. Emerg. Infect. Dis. 27, 1234\u20131237 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"19922_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jhin.2020.05.020","volume":"106","author":"D Don\u00e0","year":"2020","unstructured":"Don\u00e0, D., Di Chiara, C. & Sharland, M. Multi-drug-resistant infections in the COVID-19 era: A framework for considering the potential impact. J. Hosp. Infect. 106, 198\u2013199 (2020).","journal-title":"J. Hosp. Infect."},{"issue":"45","key":"19922_CR3","doi-asserted-by":"publisher","first-page":"2001886","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001886","volume":"25","author":"DL Monnet","year":"2020","unstructured":"Monnet, D. L. & Harbarth, S. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?. Eurosurveillance 25(45), 2001886 (2020).","journal-title":"Eurosurveillance"},{"key":"19922_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jhin.2021.09.011","volume":"117","author":"A Hirabayashi","year":"2021","unstructured":"Hirabayashi, A., Kajihara, T., Yahara, K., Shibayama, K. & Sugai, M. Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance. J. Hosp. Infect. 117, 147\u2013156 (2021).","journal-title":"J. Hosp. Infect."},{"key":"19922_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MCC.0000000000000755","volume":"26","author":"R Cant\u00f3n","year":"2020","unstructured":"Cant\u00f3n, R., Gij\u00f3n, D. & Ruiz-Garbajosa, P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr. Opin. Crit. Care 26, 433\u2013441 (2020).","journal-title":"Curr. Opin. Crit. Care"},{"key":"19922_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhin.2022.02.015","volume":"123","author":"M Bongiovanni","year":"2022","unstructured":"Bongiovanni, M., Barilaro, G., Zanini, U. & Giuliani, G. Impact of the COVID-19 pandemic on multidrug-resistant hospital-acquired bacterial infections. J. Hosp. Infect. 123, 191\u2013192 (2022).","journal-title":"J. Hosp. Infect."},{"key":"19922_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00284-016-1166-x","volume":"74","author":"AA Cisek","year":"2017","unstructured":"Cisek, A. A., D\u0105browska, I., Gregorczyk, K. P. & Wy\u017cewski, Z. Phage therapy in bacterial infections treatment: One hundred years after the discovery of bacteriophages. Curr. Microbiol. 74, 277\u2013283 (2017).","journal-title":"Curr. Microbiol."},{"key":"19922_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin, D. M., Koskella, B. & Lin, H. C. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 8, 162 (2017).","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"19922_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3855\/jidc.3573","volume":"8","author":"Z Golkar","year":"2014","unstructured":"Golkar, Z., Bagasra, O. & Pace, D. G. Bacteriophage therapy: A potential solution for the antibiotic resistance crisis. J. Infect. Dev. Ctries. 8, 129\u2013136 (2014).","journal-title":"J. Infect. Dev. Ctries."},{"issue":"10","key":"19922_CR10","doi-asserted-by":"publisher","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","volume":"61","author":"RT Schooley","year":"2017","unstructured":"Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii Infection. Antimicrob. Agents Chemother. 61(10), e00954-e1017 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19922_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730\u2013733 (2019).","journal-title":"Nat. Med."},{"key":"19922_CR12","unstructured":"Suh, G. A. et al. Considerations for the Use of Phage Therapy in Clinical Practice. (2022)."},{"key":"19922_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00612-5","author":"S Uyttebroek","year":"2022","unstructured":"Uyttebroek, S. et al. Safety and efficacy of phage therapy in difficult-to-treat infections: A systematic review. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(21)00612-5 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"19922_CR14","doi-asserted-by":"publisher","first-page":"631794","DOI":"10.3389\/fmicb.2021.631794","volume":"12","author":"S Penziner","year":"2021","unstructured":"Penziner, S., Schooley, R. T. & Pride, D. T. Animal models of phage therapy. Front. Microbiol. 12, 631794 (2021).","journal-title":"Front. Microbiol."},{"key":"19922_CR15","first-page":"31","volume":"48","author":"B Weber-Dabrowska","year":"2000","unstructured":"Weber-Dabrowska, B., Zimecki, M. & Mulczyk, M. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp. (Warsz) 48, 31\u201337 (2000).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"19922_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1471-2180-9-169","volume":"9","author":"M Zimecki","year":"2009","unstructured":"Zimecki, M. et al. Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC Microbiol. 9, 169 (2009).","journal-title":"BMC Microbiol."},{"key":"19922_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/IAI.00648-16","volume":"85","author":"PR Secor","year":"2017","unstructured":"Secor, P. R. et al. Filamentous bacteriophage produced by Pseudomonas aeruginosa Alters the. Infect. Immun. 85, 1\u201311 (2017).","journal-title":"Infect. Immun."},{"key":"19922_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3389\/fmicb.2016.01515","volume":"7","author":"A G\u00f3rski","year":"2016","unstructured":"G\u00f3rski, A. et al. Phage therapy: Combating infections with potential for evolving from merely a treatment for complications to targeting diseases. Front. Microbiol. 7, 1515 (2016).","journal-title":"Front. Microbiol."},{"issue":"8","key":"19922_CR19","doi-asserted-by":"publisher","first-page":"e00379","DOI":"10.1128\/AAC.00379-19","volume":"63","author":"N Dufour","year":"2019","unstructured":"Dufour, N., Delattre, R., Chevallereau, A., Ricard, J. D. & Debarbieux, L. Phage therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic treatment in mice. Antimicrob. Agents Chemother. 63(8), e00379-e419 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"19922_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/138920110790725401","volume":"11","author":"E Kutter","year":"2010","unstructured":"Kutter, E. et al. Phage therapy in clinical practice: Treatment of human infections. Curr. Pharm. Biotechnol. 11(1), 69\u201386 (2010).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"19922_CR21","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1007\/s00253-019-10039-2","volume":"103","author":"C Peng","year":"2019","unstructured":"Peng, C. et al. Silviavirus phage \u0278MR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human origin. Appl. Microbiol. Biotechnol. 103, 7751\u20137765 (2019).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"19922_CR22","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"87","author":"CA Dinarello","year":"1996","unstructured":"Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87, 2095\u20132147 (1996).","journal-title":"Blood"},{"key":"19922_CR23","doi-asserted-by":"publisher","unstructured":"Akira, S., Taga, T. & Kishimoto, T. Interleukin-6 in biology and medicine. 1\u201378 (1993). https:\/\/doi.org\/10.1016\/S0065-2776(08)60532-5","DOI":"10.1016\/S0065-2776(08)60532-5"},{"key":"19922_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev.med.45.1.491","volume":"45","author":"MDKJ Tracey","year":"1994","unstructured":"Tracey, M. D. K. J. & Cerami, P. D. A. TUMOR NECROSIS FACTOR: A pleiotropic cytokine and therapuetic target. Annu. Rev. Med. 45, 491\u2013503 (1994).","journal-title":"Annu. Rev. Med."},{"key":"19922_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1152\/physrev.00067.2017","volume":"99","author":"M Rodrigues","year":"2019","unstructured":"Rodrigues, M., Kosaric, N., Bonham, C. A. & Gurtner, G. C. Wound healing: A cellular perspective. Physiol. Rev. 99, 665\u2013706 (2019).","journal-title":"Physiol. Rev."},{"key":"19922_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2017.12.009","volume":"90","author":"HD Zomer","year":"2018","unstructured":"Zomer, H. D. & Trentin, A. G. Skin wound healing in humans and mice: Challenges in translational research. J. Dermatol. Sci. 90, 3\u201312 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"19922_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.suc.2020.05.007","volume":"100","author":"MD Caldwell","year":"2020","unstructured":"Caldwell, M. D. Bacteria and antibiotics in wound healing. Surg. Clin. North Am. 100, 757\u2013776 (2020).","journal-title":"Surg. Clin. North Am."},{"key":"19922_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0022034509359125","volume":"89","author":"S Guo","year":"2010","unstructured":"Guo, S. & DiPietro, L. A. Factors affecting wound healing. J. Dent. Res. 89, 219\u2013229 (2010).","journal-title":"J. Dent. Res."},{"key":"19922_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00018-020-03545-4","volume":"78","author":"W Xu","year":"2021","unstructured":"Xu, W. et al. Staphylococcus aureus impairs cutaneous wound healing by activating the expression of a gap junction protein, connexin-43 in keratinocytes. Cell. Mol. Life Sci. 78, 935\u2013947 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"19922_CR30","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/SLA.0000000000003053","volume":"271","author":"S Roy","year":"2020","unstructured":"Roy, S. et al. Staphylococcus aureus Biofilm Infection compromises wound healing by causing deficiencies in granulation tissue collagen. Ann. Surg. 271, 1174\u20131185 (2020).","journal-title":"Ann. Surg."},{"issue":"3","key":"19922_CR31","doi-asserted-by":"publisher","first-page":"e02288","DOI":"10.1128\/AAC.02288-17","volume":"62","author":"RV Ortines","year":"2018","unstructured":"Ortines, R. V. et al. Neutralizing alpha-toxin accelerates healing of Staphylococcus aureus-infected wounds in nondiabetic and diabetic mice. Antimicrob. Agents Chemother. 62(3), e02288-e2317 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19922_CR32","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1128\/AAC.01340-07","volume":"52","author":"O Simonetti","year":"2008","unstructured":"Simonetti, O. et al. RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 52, 2205\u20132211 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19922_CR33","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ajpath.2014.11.030","volume":"185","author":"SD Kobayashi","year":"2015","unstructured":"Kobayashi, S. D., Malachowa, N. & DeLeo, F. R. Pathogenesis of staphylococcus aureus abscesses. Am. J. Pathol. 185, 1518\u20131527 (2015).","journal-title":"Am. J. Pathol."},{"key":"19922_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright, K. E., Chan, B. K., Koff, J. L. & Turner, P. E. Phage therapy: A renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe 25, 219\u2013232 (2019).","journal-title":"Cell Host Microbe"},{"key":"19922_CR35","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1128\/AEM.01789-14","volume":"80","author":"DR Alves","year":"2014","unstructured":"Alves, D. R. et al. Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus Biofilm formation. Appl. Environ. Microbiol. 80, 6694\u20136703 (2014).","journal-title":"Appl. Environ. Microbiol."},{"issue":"10","key":"19922_CR36","doi-asserted-by":"publisher","first-page":"e2008007118","DOI":"10.1073\/pnas.2008007118","volume":"118","author":"BA Berryhill","year":"2021","unstructured":"Berryhill, B. A., Huseby, D. L., McCall, I. C., Hughes, D. & Levin, B. R. Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections. Proc. Natl. Acad. Sci. 118(10), e2008007118 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"19922_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/1040841X.2020.1729695","volume":"46","author":"LDR Melo","year":"2020","unstructured":"Melo, L. D. R., Oliveira, H., Pires, D. P., Dabrowska, K. & Azeredo, J. Phage therapy efficacy: A review of the last 10 years of preclinical studies. Crit. Rev. Microbiol. 46, 78\u201399 (2020).","journal-title":"Crit. Rev. Microbiol."},{"key":"19922_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-12-394438-2.00002-5","volume":"83","author":"A G\u00f3rski","year":"2012","unstructured":"G\u00f3rski, A. et al. Phage as a modulator of immune responses: Practical implications for phage therapy. Adv. Virus Res. 83, 41\u201371 (2012).","journal-title":"Adv. Virus Res."},{"key":"19922_CR39","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","volume":"7","author":"JD Van Belleghem","year":"2017","unstructured":"Van Belleghem, J. D., Clement, F., Merabishvili, M., Lavigne, R. & Vaneechoutte, M. Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci. Rep. 7, 8004 (2017).","journal-title":"Sci. Rep."},{"key":"19922_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/emm.2007.27","volume":"39","author":"E-J Lim","year":"2007","unstructured":"Lim, E.-J. et al. Toll-like receptor 9 dependent activation of MAPK and NF-\u03baB is required for the CpG ODN-induced matrix metalloproteinase-9 expression. Exp. Mol. Med. 39, 239\u2013245 (2007).","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"19922_CR41","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","volume":"109","author":"PJ Jost","year":"2007","unstructured":"Jost, P. J. & Ruland, J. Aberrant NF-\u03baB signaling in lymphoma: Mechanisms, consequences, and therapeutic implications. Blood 109(7), 2700\u20132707 (2007).","journal-title":"Blood"},{"key":"19922_CR42","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fmicb.2018.01614","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Staphylococcus aureus bacteriophage suppresses LPS-induced inflammation in MAC-T bovine mammary epithelial cells. Front. Microbiol. 9, 1614 (2018).","journal-title":"Front. Microbiol."},{"key":"19922_CR43","doi-asserted-by":"publisher","first-page":"973","DOI":"10.15252\/emmm.201404525","volume":"7","author":"R Sartorius","year":"2015","unstructured":"Sartorius, R. et al. Antigen delivery by filamentous bacteriophage fd displaying an anti\u2013DEC\u2013205 single\u2013chain variable fragment confers adjuvanticity by triggering a TLR9\u2013mediated immune response. EMBO Mol. Med. 7, 973\u2013988 (2015).","journal-title":"EMBO Mol. Med."},{"key":"19922_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","volume":"19","author":"T Kawai","year":"2007","unstructured":"Kawai, T. & Akira, S. TLR signaling. Semin. Immunol. 19, 24\u201332 (2007).","journal-title":"Semin. Immunol."},{"key":"19922_CR45","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.1073\/pnas.91.26.12837","volume":"91","author":"S Karlin","year":"1994","unstructured":"Karlin, S., Ladunga, I. & Blaisdell, B. E. Heterogeneity of genomes: measures and values. Proc. Natl. Acad. Sci. 91, 12837\u201312841 (1994).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"19922_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1053\/j.gastro.2010.08.020","volume":"140","author":"J Petrasek","year":"2011","unstructured":"Petrasek, J., Dolganiuc, A., Csak, T., Kurt-Jones, E. A. & Szabo, G. Type I interferons protect from toll-like receptor 9\u2013associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology 140, 697-708.e4 (2011).","journal-title":"Gastroenterology"},{"key":"19922_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature03308","volume":"434","author":"A Takaoka","year":"2005","unstructured":"Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243\u2013249 (2005).","journal-title":"Nature"},{"key":"19922_CR48","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature03547","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda, K. et al. Spatiotemporal regulation of MyD88\u2013IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035\u20131040 (2005).","journal-title":"Nature"},{"key":"19922_CR49","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.4049\/jimmunol.179.10.6933","volume":"179","author":"LS Miller","year":"2007","unstructured":"Miller, L. S. et al. Inflammasome-mediated production of IL-1\u03b2 Is required for neutrophil recruitment against Staphylococcus aureus In Vivo. J. Immunol. 179, 6933\u20136942 (2007).","journal-title":"J. Immunol."},{"key":"19922_CR50","doi-asserted-by":"publisher","first-page":"105671","DOI":"10.1016\/j.micpath.2022.105671","volume":"169","author":"Z Gong","year":"2022","unstructured":"Gong, Z. et al. Microbial Pathogenesis TLR2, TLR4, and NLRP3 mediated the balance between host immune-driven resistance and tolerance in Staphylococcus aureus -infected mice. Microb. Pathog. 169, 105671 (2022).","journal-title":"Microb. Pathog."},{"issue":"2","key":"19922_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000499604","volume":"12","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. Prostaglandin E2 regulates activation of mouse peritoneal macrophages by staphylococcus aureus through toll-like receptor 2, toll-like receptor 4, and NLRP3 Inflammasome Signaling. J. Innate Immun. 12(2), 154\u2013169 (2020).","journal-title":"J. Innate Immun."},{"key":"19922_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2020.00244","volume":"11","author":"PR Secor","year":"2020","unstructured":"Secor, P. R. et al. Pf bacteriophage and their impact on pseudomonas virulence, mammalian immunity, and chronic infections. Front. Immunol. 11, 244 (2020).","journal-title":"Front. Immunol."},{"key":"19922_CR53","doi-asserted-by":"publisher","first-page":"eeat6691","DOI":"10.1126\/science.aat9691","volume":"363","author":"JM Sweere","year":"2019","unstructured":"Sweere, J. M. et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science 363, eeat6691 (2019).","journal-title":"Science"},{"key":"19922_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1158\/1078-0432.361.11.1","volume":"11","author":"KA Mason","year":"2005","unstructured":"Mason, K. A. et al. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. Clin. Cancer Res. 11, 361\u2013369 (2005).","journal-title":"Clin. Cancer Res."},{"key":"19922_CR55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s12275-011-1512-4","volume":"49","author":"BR Tiwari","year":"2011","unstructured":"Tiwari, B. R., Kim, S., Rahman, M. & Kim, J. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models. J. Microbiol. 49, 994\u2013999 (2011).","journal-title":"J. Microbiol."},{"key":"19922_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","volume":"22","author":"DR Roach","year":"2017","unstructured":"Roach, D. R. et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe 22, 38-47.e4 (2017).","journal-title":"Cell Host Microbe"},{"key":"19922_CR57","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.transproceed.2005.12.073","volume":"38","author":"A G\u00f3rski","year":"2006","unstructured":"G\u00f3rski, A. et al. Bacteriophages and transplantation tolerance. Transplant. Proc. 38, 331\u2013333 (2006).","journal-title":"Transplant. Proc."},{"key":"19922_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3612015","volume":"2017","author":"R Mi\u0119dzybrodzki","year":"2017","unstructured":"Mi\u0119dzybrodzki, R. et al. In Vivo studies on the influence of bacteriophage preparations on the autoimmune inflammatory process. Biomed Res. Int. 2017, 1\u20139 (2017).","journal-title":"Biomed Res. Int."},{"key":"19922_CR59","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jgar.2022.01.019","volume":"28","author":"A G\u00f3rski","year":"2022","unstructured":"G\u00f3rski, A., Borysowski, J. & Mi\u0119dzybrodzki, R. The contribution of phage therapy to medical knowledge. J. Glob. Antimicrob. Resist. 28, 238\u2013240 (2022).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"19922_CR60","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41423-020-00532-4","volume":"18","author":"S Federici","year":"2021","unstructured":"Federici, S., Nobs, S. P. & Elinav, E. Phages and their potential to modulate the microbiome and immunity. Cell. Mol. Immunol. 18, 889\u2013904 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"19922_CR61","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860\u2013875 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"19922_CR62","doi-asserted-by":"publisher","first-page":"14802","DOI":"10.1038\/srep14802","volume":"5","author":"K Hodyra-Stefaniak","year":"2015","unstructured":"Hodyra-Stefaniak, K. et al. Mammalian Host-Versus-Phage immune response determines phage fate in vivo. Sci. Rep. 5, 14802 (2015).","journal-title":"Sci. Rep."},{"key":"19922_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12223-016-0471-x","volume":"62","author":"S Sharma","year":"2017","unstructured":"Sharma, S. et al. Bacteriophages and its applications: an overview. Folia Microbiol. (Praha) 62, 17\u201355 (2017).","journal-title":"Folia Microbiol. (Praha)"},{"key":"19922_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.7883\/yoken.JJID.2019.162","volume":"73","author":"T Hanawa","year":"2020","unstructured":"Hanawa, T. et al. Skin and soft tissue infections caused by different genotypes of PVL-positive community-acquired methicillin-resistant Staphylococcus aureus strains. Jpn. J. Infect. Dis. 73, 72\u201375 (2020).","journal-title":"Jpn. J. Infect. Dis."},{"key":"19922_CR65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/abio.1996.9940","volume":"245","author":"Y Xia","year":"1997","unstructured":"Xia, Y. & Zweier, J. L. Measurement of myeloperoxidase in leukocyte-containing tissues. Anal. Biochem. 245, 93\u201396 (1997).","journal-title":"Anal. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19922-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:09:53Z","timestamp":1663585793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19922-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19922"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19922-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15656"}}